105 related articles for article (PubMed ID: 8896517)
1. Interleukin-12 administered in vivo decreases human NK cell cytotoxicity and antibody-dependent cellular cytotoxicity to human immunodeficiency virus-infected cells.
Kohl S; Sigaroudinia M; Charlebois ED; Jacobson MA
J Infect Dis; 1996 Nov; 174(5):1105-8. PubMed ID: 8896517
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
Loubeau M; Ahmad A; Toma E; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae Sivmac251-infected Macaca fascicularis.
Poaty-Mavoungou V; Touré FS; Tevi-Benissan C; Mavoungou E
Viral Immunol; 2002; 15(1):197-212. PubMed ID: 11952142
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2(IL-2), IL-12, and IL-15.
Lin SJ; Roberts RL; Ank BJ; Nguyen QH; Thomas EK; Stiehm ER
Clin Immunol Immunopathol; 1997 Feb; 82(2):163-73. PubMed ID: 9000485
[TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
[TBL] [Abstract][Full Text] [Related]
6. Characterization of natural killer and antibody-dependent cellular cytotoxicity of preterm infants against human immunodeficiency virus-infected cells.
Merrill JD; Sigaroudinia M; Kohl S
Pediatr Res; 1996 Sep; 40(3):498-503. PubMed ID: 8865290
[TBL] [Abstract][Full Text] [Related]
7. Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection.
Lin SJ; Roberts RL; Ank BJ; Nguyen QH; Thomas EK; Stiehm ER
J Clin Immunol; 1998 Sep; 18(5):335-45. PubMed ID: 9793826
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2) and IL-12.
Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Lau CK; Stiehm ER
Clin Diagn Lab Immunol; 1998 Jan; 5(1):98-104. PubMed ID: 9455889
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults.
Jenkins M; Mills J; Kohl S
Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
11. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
[TBL] [Abstract][Full Text] [Related]
12. Influence of naproxen therapy on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus.
Gonik B; Loo LS; Bigelow R; Kohl S
J Reprod Med; 1984 Oct; 29(10):722-6. PubMed ID: 6512781
[TBL] [Abstract][Full Text] [Related]
13. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
[TBL] [Abstract][Full Text] [Related]
14. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
[TBL] [Abstract][Full Text] [Related]
15. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture.
Choi SS; Chhabra VS; Nguyen QH; Ank BJ; Stiehm ER; Roberts RL
Clin Diagn Lab Immunol; 2004 Sep; 11(5):879-88. PubMed ID: 15358647
[TBL] [Abstract][Full Text] [Related]
17. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
[TBL] [Abstract][Full Text] [Related]
18. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
Caligiuri MA; Murray C; Robertson MJ; Wang E; Cochran K; Cameron C; Schow P; Ross ME; Klumpp TR; Soiffer RJ
J Clin Invest; 1993 Jan; 91(1):123-32. PubMed ID: 7678599
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type-1 infected patients.
Sirianni MC; Ansotegui IJ; Aiuti F; Wigzell H
Scand J Immunol; 1994 Jul; 40(1):83-6. PubMed ID: 7913248
[TBL] [Abstract][Full Text] [Related]
20. Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL.
Jacobson MA; Hardy D; Connick E; Watson J; DeBruin M
J Infect Dis; 2000 Oct; 182(4):1070-6. PubMed ID: 10979901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
